Compare · SGFY vs WGS
SGFY vs WGS
Side-by-side comparison of Signify Health Inc. (SGFY) and GeneDx Holdings Corp. (WGS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both SGFY and WGS operate in Retail: Computer Software & Peripheral Equipment (Technology), so they compete in similar markets.
- SGFY is the larger of the two at $2.12B, about 1.4x WGS ($1.55B).
- WGS has hit the wire 3 times in the past 4 weeks while SGFY has been quiet.
- SGFY has more recent analyst coverage (13 ratings vs 8 for WGS).
- Company
- Signify Health Inc.
- GeneDx Holdings Corp.
- Price
- $30.50+0.07%
- $52.78+0.90%
- Market cap
- $2.12B
- $1.55B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Retail: Computer Software & Peripheral Equipment
- Retail: Computer Software & Peripheral Equipment
- Exchange
- NYSE
- NASDAQ
- IPO
- 2021
- 2020
- News (4w)
- 0
- 3
- Recent ratings
- 13
- 8
Signify Health Inc.
Signify Health, Inc. operates a healthcare platform that utilizes analytics, technology, and healthcare provider networks in the United States. The company operates in two segments, Home & Community Services and Episodes of Care Services. The Home & Community Services segment offers health evaluations performed within the patient's home or at a healthcare provider facility primarily to Medicare Advantage health plans; diagnostic screening and other ancillary services; and services to address healthcare concerns related to social determinants of health. The Episodes of Care Services segment provides services to enhance the healthcare delivery through developing and managing episodic payment programs in partnership with healthcare providers primarily under the Medicare Bundled Payment for Care Improvement Advanced program with Centers for Medicare and Medicaid Services; and care management services. Its customers include health plans, governments, employers, health systems, and physician groups. The company was founded in 2017 and is headquartered in Dallas, Texas with additional offices in Austin, New York, Norwalk, and Rapid City.
Latest SGFY
- UnitedHealth Group, CVS Health, Oracle, And This US Shale Oil Titan Ignite CNBC's 'Final Trades' Showdown
- SEC Form 15-12G filed by Signify Health Inc.
- SEC Form 25-NSE filed by Signify Health Inc.
- SEC Form 4 filed by Builder Josh
- SEC Form S-8 POS filed by Signify Health Inc.
- SEC Form 4 filed by Armbrester Bradford Kyle
- SEC Form 4 filed by Rothman Marc D
- SEC Form 4 filed by Notini Albert A
- SEC Form 4 filed by Dixon Heather Brianne
- SEC Form 4 filed by Senneff Steve
Latest WGS
- CHIEF FINANCIAL OFFICER Feeley Kevin converted options into 717 shares and sold $19,092 worth of shares (369 units at $51.74), increasing direct ownership by 1.00% to 35,290 units (SEC Form 4) to cover taxes
- GeneDx to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
- Director Casdin Capital, Llc bought $21,459,736 worth of shares (500,000 units at $42.92) (SEC Form 4)
- Director Meister Keith A. bought $13,765,345 worth of shares (351,273 units at $39.19) (SEC Form 4)
- Director Meister Keith A. bought $46,806,729 worth of shares (1,205,147 units at $38.84) (SEC Form 4)
- SEC Form 4 filed by Director Casdin Capital, Llc
- SEC Form 10-Q filed by GeneDx Holdings Corp.
- GeneDx Holdings Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- GeneDx Reports First Quarter 2026 Financial Results and Updates Full-Year Outlook
- CHIEF EXECUTIVE OFFICER Stueland Katherine converted options into 3,874 shares and sold $141,595 worth of shares (2,172 units at $65.19), increasing direct ownership by 2% to 93,216 units (SEC Form 4) (for tax liability)